Key clinical point: A proposed Trump administration plan for paying for drugs under Medicare Part B has raised red flags for doctors.
Major finding: The Centers for Medicare & Medicaid Services announced that it will test paying for Part B drugs by more closely aligning those payments with international rates.
A CMS Fact Sheet on the ANPRM International Pricing Index Model for Medicare Part B Drugs
This Week's Must Reads
Intensity modulated radiation therapy may be preferable in children with extremity nonrhabdomyosarcoma soft-tissue sarcomas, Source: Rao A et al. Intl J Rad Oncology*Biology*Physics; Jan. 2019, 38-44. https://doi.org/10.1016/j.ijrobp.2018.09.005
Outcomes better in TNBC with adjuvant chemotherapy within 30 days of surgery, Morante Z et al., SABCS 2018 Abstract GS2-05
TAO: Nonwhite ethnicity, limb infection predict poor prognosis, Le Joncour A et al. Arthritis Rheumatol. 2018;70(Suppl 10): Abstract 1885
Thrombolysis for acute ischemic stroke safe in GI malignancy, Inohara T et al. Circulation. 2018 Nov 6;138[suppl 1], Abstract A12291
Ten years of anastrozole boosts disease-free survival, Ohtani S et al. SABCS 2018, Abstract GS3-04
Must Reads in Practice Management
Open enrollment surge doubles plans selected , Centers for Medicare & Medicaid Services
Residents get less parental leave than faculty physicians, Magudia K et al. JAMA. 2018 Dec 11;320[22)]:2372-4; Varda B et al. JAMA. 2018 Dec 11;320:2374-7
Physician burnout linked to EHRs, Gardner R et al. J Am Med Inform Assoc. doi: 10.1093/jamia/ocy145.
Most physicians do not use telemedicine, Kane C et al. Health Affairs. 2018. doi: 10.1377/hlthaff.2018.05077
Health care spending slowed but fewer insured, Martin A et al. Health Affairs. 2018. doi: 10.1377/hlthaff.2018.05085